294 related articles for article (PubMed ID: 34427754)
21. Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307.
Krauss GL; Perucca E; Ben-Menachem E; Kwan P; Shih JJ; Clément JF; Wang X; Bagul M; Gee M; Zhu J; Squillacote D
Epilepsia; 2014 Jul; 55(7):1058-68. PubMed ID: 24867391
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of perampanel in children and adolescents with pharmacoresistant epilepsy: The first real-world evaluation in Asian pediatric neurology clinics.
Lin KL; Lin JJ; Chou ML; Hung PC; Hsieh MY; Chou IJ; Lim SN; Wu T; Wang HS
Epilepsy Behav; 2018 Aug; 85():188-194. PubMed ID: 30032806
[TBL] [Abstract][Full Text] [Related]
23. A retrospective, real-world experience of perampanel monotherapy in patient with first new onset focal seizure: A Thailand experience.
Chinvarun Y
Epilepsia Open; 2022 Mar; 7(1):67-74. PubMed ID: 34741590
[TBL] [Abstract][Full Text] [Related]
24. Value of drug level concentrations of brivaracetam, lacosamide, and perampanel in care of people with epilepsy.
Hentschel M; Stoffel-Wagner B; Surges R; von Wrede R; Dolscheid-Pommerich RC
Epilepsia; 2024 Mar; 65(3):620-629. PubMed ID: 38158709
[TBL] [Abstract][Full Text] [Related]
25. Long-term efficacy and safety of perampanel as a first add-on therapy in patients with focal epilepsy: Three-year extension study.
Im K; Lee SA; Kim JH; Kim DW; Lee SK; Seo DW; Lee JW
Epilepsy Behav; 2021 Dec; 125():108407. PubMed ID: 34785411
[TBL] [Abstract][Full Text] [Related]
26. Perampanel effectiveness and safety as early add-on treatment for focal-onset seizures: PEREAGAL study.
Rodríguez-Osorio X; Lema-Facal T; Rubio-Nazábal E; Castro-Vilanova MD; Pato-Pato A; Abella-Corral J; Corredera E; López-Ferreiro A; Puy-Núñez A; López-González FJ
Epilepsy Res; 2021 May; 172():106570. PubMed ID: 33621770
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of perampanel as the first add-on therapy for children with epilepsy: A real-world multicenter prospective observational study.
Mai J; Li H; He Y; Huang T; Lin C; Lan S; Xiao X; He S; Lu X; Chen L; Li B; Luo X; Wang H; Liao J; Cao D
Seizure; 2024 Apr; 117():44-49. PubMed ID: 38308908
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of adjunctive lacosamide in Chinese and Japanese adults with epilepsy and focal seizures: A long-term, open-label extension of a randomized, controlled trial.
Inoue Y; Liao W; Wang X; Du X; Tennigkeit F; Sasamoto H; Osakabe T; Hoshii N; Yuen N; Hong Z
Epilepsy Res; 2021 Oct; 176():106705. PubMed ID: 34246118
[TBL] [Abstract][Full Text] [Related]
29. Real-world evaluation of perampanel effectiveness in Japanese adolescents with epilepsy.
Inoue Y; Sumitomo K; Matsutani K; Ishii M
Epileptic Disord; 2022 Oct; 24(5):813-821. PubMed ID: 35792849
[TBL] [Abstract][Full Text] [Related]
30. Perampanel as adjunctive therapy in drug resistant epilepsy in adolescents and children waiting for epilepsy surgery: A multicenter observational study in Thailand.
Suwanpakdee P; Saksritavee B; Likasitthananon N; Simasathien T; Deesudchit T; Khongkhatithum C; Viravan S; Nabangchang C
Seizure; 2022 Aug; 100():103-108. PubMed ID: 35820301
[TBL] [Abstract][Full Text] [Related]
31. Sustained seizure freedom with adjunctive perampanel in patients with convulsive seizures: Post hoc analysis of open-label extension studies 307 and 332.
Resnick T; Patten A; Ngo LY; Malhotra M
Epilepsy Behav; 2022 Mar; 128():108528. PubMed ID: 35078116
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness and safety of perampanel as adjunctive therapy among Chinese patients with focal-onset epilepsy: A real-world prospective observational study.
Wang Q; Xu Y; Chen Y; Wu X; Ge Y; Zhu G
Epilepsy Behav; 2022 Nov; 136():108937. PubMed ID: 36215830
[TBL] [Abstract][Full Text] [Related]
33. Perampanel in real-world clinical care of patients with epilepsy: Interim analysis of a phase IV study.
Wheless J; Wechsler RT; Lancman M; Aboumatar S; Patten A; Malhotra M
Epilepsia Open; 2021 Mar; 6(1):79-89. PubMed ID: 33681651
[TBL] [Abstract][Full Text] [Related]
34. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
35. PROVE: Retrospective, non-interventional, Phase IV study of perampanel in real-world clinical care of patients with epilepsy.
Wechsler RT; Wheless J; Zafar M; Huesmann GR; Lancman M; Segal E; Chez M; Aboumatar S; Patten A; Salah A; Malhotra M
Epilepsia Open; 2022 Jun; 7(2):293-305. PubMed ID: 34942053
[TBL] [Abstract][Full Text] [Related]
36. Phase IV PROVE study: Perampanel in real-world clinical care of pediatric patients with epilepsy.
Moretz K; Wheless J; Santos C; Segal E; Lancman M; Patten A; Malhotra M
Eur J Paediatr Neurol; 2024 May; 50():23-30. PubMed ID: 38569352
[TBL] [Abstract][Full Text] [Related]
37. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study.
Villanueva V; Montoya J; Castillo A; Mauri-Llerda JÁ; Giner P; López-González FJ; Piera A; Villanueva-Hernández P; Bertol V; Garcia-Escrivá A; Garcia-Peñas JJ; Garamendi I; Esteve-Belloch P; Baiges-Octavio JJ; Miró J; Falip M; Garcés M; Gómez A; Gil-López FJ; Carreño M; Rodriguez-Uranga JJ; Campos D; Bonet M; Querol R; Molins A; Tortosa D; Salas-Puig J
Epilepsia; 2018 Sep; 59(9):1740-1752. PubMed ID: 30062784
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies.
Piña-Garza JE; Rosenfeld W; Saeki K; Villanueva V; Yoshinaga H; Patten A; Williams B; Malhotra M
Epilepsy Behav; 2020 Mar; 104(Pt A):106876. PubMed ID: 31954998
[TBL] [Abstract][Full Text] [Related]
39. Perampanel treatment in highly drug-resistant epilepsies including nonsurgical candidates and failed surgery.
Limotai C; Jirasakuldej S
Epilepsy Behav; 2021 Aug; 121(Pt A):108073. PubMed ID: 34058494
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the effectiveness and tolerability of perampanel and brivaracetam: a real-world, observational, retrospective study.
Liguori C; Manfredi N; Renna R; Izzi F; Pagliuca M; Pagliuca F; Mercuri NB; Fabio P
Epileptic Disord; 2020 Jun; 22(3):309-316. PubMed ID: 32540833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
